eli lilly compound tirzepatide finds impurity in compounded version of its weight-loss drug, warns of health risks Lilly launches lower-price weight-loss drug

Compounded formulations are not FDA-approved and are only prescribed when medically necessary and after provider evaluation

Popular options include: Semaglutide marketed as Ozempic (T2D) and Wegovy (weight management) Tirzepatide a newer dual GLP1/GIP agonist available as Mounjaro (diabetes) and Zepbound (weight management) These treatments are delivered via once-weekly injection (with some oral options developing) and require close monitoring and a thoughtful approach to support long-term benefits

The Weight Loss Journey with Retatrutide : Weight loss is often a challenging and complex journey, but retatrutide has shown tremendous promise in helping individuals achieve and sustain their weight loss goals

Bottom line While touted on social media as natures Ozempic, available research shows that berberine may have only a modest impact on weight loss